en · de · es · pt
bpc-157-notes.peptides1126.com › Guide › Research Literature And Evidence Gaps — Reference Sheet

Research Literature And Evidence Gaps — Reference Sheet

By Editorial Desk · published 2026-05-29 · last reviewed 2026-06-12 · Guide

lyophilized powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-06-12. Numbers and descriptions here follow the published literature rather than marketing material.

Research Literature and Evidence Gaps

Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.

Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.

Identity And Research Background

The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.

Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.

Bpc-157 at a glance

PropertyValueNotes
Study speciesRodents, mainly ratsMost reports use surgically induced injury models
Typical administration routeSubcutaneous or intraperitoneal injectionRoutes differ between reports, which complicates comparison
Human trial evidenceLimited, small-scale reportsNo large randomized trial in indexed journals
Reported outcome categoriesMucosal healing, tendon repair, vascular recoveryEndpoints are not standardized across studies
Mechanism statusNot establishedProposed pathways lack direct confirmation

Background and Research Status

Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.

BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.

Related pages on this site

Background and Chemical Identity

The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.

Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.

Storage, Solubility, And Analysis

Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.

In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.

Handling, Storage, and Quality Control

Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.

In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.

Further detail

The Garinagu (singular Garifuna), at around 4.5% of the population, are a mix of West/Central African, Arawak, and Island Carib ancestry. Though they were captives removed from their homelands, these people were never documented as slaves. The two prevailing theories are that, in 1635, they were either the survivors of two recorded shipwrecks or somehow took over the ship they came on. Throughout history they have been incorrectly labelled as Black Caribs. When the British took over Saint Vincent and the Grenadines after the Treaty of Paris in 1763, they were opposed by French settlers and their Garinagu allies. The Garinagu eventually surrendered to the British in 1796. The British separated the more African-looking Garifunas from the more indigenous-looking ones. 5,000 Garinagu were exiled from the Grenadine island of Baliceaux. About 2,500 of them survived the voyage to Roatán, an island off the coast of Honduras. The Garifuna language belongs to the Arawakan language family, but has a large number of loanwords from Carib languages and from English. Because Roatán was too small and infertile to support their population, the Garinagu petitioned the Spanish authorities of Honduras to be allowed to settle on the mainland coast. The Spanish employed them as soldiers, and they spread along the Caribbean coast of Central America. The Garinagu settled in Seine Bight, Punta Gorda and Punta Negra, Belize, by way of Honduras as early as 1802. In Belize, 19 November 1832 is the date officially recognized as "Garifuna Settlement Day" in Dangriga.

=== Alternative medicine === A 2018 Cochrane review on acupuncture and related interventions for the treatment of carpal tunnel syndrome concluded that "Acupuncture and laser acupuncture may have little or no effect in the short term on symptoms of carpal tunnel syndrome (CTS) in comparison with placebo or sham acupuncture." It was also noted that all studies had an unclear or high overall risk of bias and that all evidence was of low or very low quality.

==== One-stepwise pyrolysis and two-stepwise pyrolysis for tobacco waste ==== Pyrolysis has also been used in trying to mitigate tobacco waste. One method was done where tobacco waste was separated into two categories, TLW (Tobacco Leaf Waste) and TSW (Tobacco Stick Waste). TLW was determined to be any waste from cigarettes and TSW was determined to be any waste from electronic cigarettes. Both TLW and TSW were dried at 80 °C for 24 hours and stored in a desiccator. Samples were grounded so that the contents were uniform. Tobacco Waste (TW) also contains inorganic (metal) contents, which was determined using an inductively coupled plasma-optical spectrometer. Thermo-gravimetric analysis was used to thermally degrade four samples (TLW, TSW, glycerol, and guar gum) and monitored under specific dynamic temperature conditions. About one gram of both TLW and TSW were used in the pyrolysis tests. During these analysis tests, CO2 and N2 were used as atmospheres inside of a tubular reactor that was built using quartz tubing. For both CO2 and N2 atmospheres the flow rate was 100 mL min−1. External heating was created via a tubular furnace. The pyrogenic products were classified into three phases. The first phase was biochar, a solid residue produced by the reactor at 650 °C. The second phase liquid hydrocarbons were collected by a cold solvent trap and sorted by using chromatography. The third and final phase was analyzed using an online micro GC unit and those pyrolysates were gases.

Methylestradiol, or 17α-methylestradiol (17α-ME), also known as 17α-methylestra-1,3,5(10)-triene-3,17β-diol, is a synthetic estrane steroid and a derivative of estradiol. It is specifically the derivative of estradiol with a methyl group at the C17α positions. Closely related steroids include ethinylestradiol (17α-ethynylestradiol) and ethylestradiol (17α-ethylestradiol). The C3 cyclopentyl ether of methylestradiol has been studied and shows greater oral potency than methylestradiol in animals, similarly to quinestrol (ethinylestradiol 3-cyclopentyl ether) and quinestradol (estriol 3-cyclopentyl ether).

Sources: en.wikipedia.org

Background from the literature

Silanization is the attachment of an organosilyl group to some chemical species. Almost always, silanization is the conversion of a silanol-terminated surface to an alkylsiloxy-terminated surface. This conversion confers hydrophobicity to a previously hydrophilic surface. This process is often used to modify the surface properties of glass, silicon, alumina, quartz, and metal oxide substrates, which all have an abundance of hydroxyl groups. Silanization differs from silylation, which usually refers to attachment of organosilicon groups to molecular substrates.

== Inhibitors == Elafin, the skin-derived elastase inhibitor, has been shown to be a potent and specific inhibitor of both the porcine homolog of ELA1 and human leukocyte elastase in vitro. Elafin is expressed by epidermal keratinocytes under hyperproliferative conditions such as psoriasis and wound healing. It has also been reported to be present in many other adult epithelia that are exposed to environmental stimuli: tongue, plate, lingual tonsils, gingiva, pharynx, epiglottis, vocal fold, esophagus, uterine cervix, vagina, and hair follicles. In all these tissues, the presence of inflammatory cells is physiologic and elafin expression is believed to protect against leukocyte proteases, thereby helping to maintain epithelial integrity. Elafin on the contrary has never been found in the basal layer in any type of epithelial tissue. Indeed, elafin is virtually absent in normal human epidermis. The other known elastase inhibitor, SLPI, however, has been reported to be expressed in the basal keratinocytes suggesting that this may be the major elastase inhibitor in normal epidermis. Alpha 1-antitrypsin and alpha-2-macroglobulin are human serum protease inhibitors that completely inhibit the general proteolytic activity of pancreatic elastase 1 and 2. It has been observed that a protease must be active in order to bind to these two inhibitors. Studies proved that the activity of elastase 2 was enhanced in 25-250 mM NaCl. The activity of elastase 2 in NaCl approached approximately twice the activity without NaCl. Elastase 1 is slightly inhibited above 150 mM NaCl

Melo's government also became known for his large-scale program of the concession of programs and public spaces to private initiatives, saying that the privatization program "is in the DNA" of his government. It was put forth that the municipality did not have the conditions to maintain these services adequately and that the partnerships would bring qualified individuals to the system and health benefits for the population. During his electoral campaign, he declared that services should be public, but backed up by private partnerships. Places for the dispersion of the equipment included Auditório Araújo Viana, Teatro de Câmara Túlio Piva, Parque da Harmonia, and stretch 1 of the Orla do Guaíba, some of them completing a process started during the previous administration. They had expected new concessions at Farroupilha, Moinhos de Vento and Marinha do Brasil parks; from stretches 2 and 3 of the Orla do Guaíba; Hospital de Pronto Socorro and Hospital Materno-Infantil Presidente Vargas; the Usina do Gasômetro; with garbage collection and water and sewage treatment; green areas in the surrounding areas of the Aeromóvel and the area around the Joaquim Felizardo Museum of Porto Alegre. The public transport company Carris was privatized, with its assets being sold. The program came to be criticized for devaluing the public character of services and spaces, and to allow them to be exploited commercially, along with the program's proposals having little transparency and without the necessary dialogue with the community.

2C (2C-x) is a general name for the family of psychedelic phenethylamines containing methoxy groups on the 2 and 5 positions of a benzene ring. Most of these compounds also carry lipophilic substituents at the 4 position, usually resulting in more potent and more metabolically stable and longer acting compounds. Most of the early 2C drugs were developed by Alexander Shulgin in the 1970s and 1980s and were reviewed in his 1991 book PiHKAL (Phenethylamines I Have Known And Loved). 2C-B is the most popular of the 2C drugs. The prefix "2C" comes from the fact that they are phenethylamines rather than amphetamines and have two carbon atoms in their side chain, whereas the suffix (e.g., the "–B" or "bromo" in the case of 2C–B) refers to the substituent at the 4-position.

Trifluridine (also called trifluorothymidine; abbreviation TFT or FTD) is an anti-herpesvirus antiviral drug, used primarily as prescription eyedrops. It was sold under the trade name Viroptic by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now wholly owned by King Pharmaceuticals. Trifluridine was approved for medical use in 1980. It is also a component of the anti-cancer drug trifluridine/tipiracil, which is taken by mouth.

Sources: en.wikipedia.org

Further detail

==== Off-Target Effects of Gene Knockdown ==== Extensive efforts in computational biology have been directed toward the design of successful dsRNA reagents that maximize gene knockdown but minimize "off-target" effects. Off-target effects arise when an introduced RNA has a base sequence that can pair with and thus reduce the expression of multiple genes. Such problems occur more frequently when the dsRNA contains repetitive sequences. It has been estimated from studying the genomes of humans, C. elegans and S. pombe that about 10% of possible siRNAs have substantial off-target effects. A multitude of software tools have been developed implementing algorithms for the design of general mammal-specific, and virus-specific siRNAs that are automatically checked for possible cross-reactivity. Depending on the organism and experimental system, the exogenous RNA may be a long strand designed to be cleaved by Dicer, or short RNAs designed to serve as siRNA substrates. In most mammalian cells, shorter RNAs are used because long double-stranded RNA molecules induce the mammalian interferon response, a form of innate immunity that reacts nonspecifically to foreign genetic material. Mouse oocytes and cells from early mouse embryos lack this reaction to exogenous dsRNA and are therefore a common model system for studying mammalian gene-knockdown effects.

=== Non-peptide === Adenosine Anamorelin (ONO-7643, RC-1291, ST-1291) Capromorelin (CP-424391) Ibutamoren (MK-677, MK-0677, L-163191, LUM-201) Macimorelin (AEZS-130, JMV 1843) SM-130686 Note that while ulimorelin is a ghrelin receptor agonist, it is not a GHS as it is peripherally selective and has little or no effect on GH secretion. Likewise, adenosine is capable of eliciting a hunger response as a ghrelin agonist but has little to no effect on GH secretion.

At 11:07, radar detected another, larger attack. This second wave consisted of 107 aircraft. They were met while still 60 miles (97 km) out, and at least 70 of these aircraft were shot down before reaching the ships. Six attacked Rear Admiral Alfred E. Montgomery's group, nearly hitting two of the carriers and causing casualties on each. Four of the six were shot down. A small group of torpedo aircraft attacked Enterprise, with one torpedo exploding in the wake of the ship. Three other torpedo aircraft attacked the light carrier Princeton and were shot down. In all, 97 of the 107 attacking aircraft were destroyed. A third raid, consisting of 47 aircraft, came in from the north. It was intercepted by 40 fighters at 13:00, while 50 miles (80 km) out from the task force. Seven Japanese aircraft were shot down. A few broke through and made an ineffective attack on Task Group 58.4. Many others did not press home their attacks. This raid therefore suffered less than the others, and 40 of its aircraft managed to return to their carriers. A fourth Japanese raid was launched between 11:00 and 11:30, but pilots had been given an incorrect position for the U.S. fleet and could not locate it. They broke into two loose groups and turned for Guam and Rota to refuel. One group flying toward Rota stumbled upon Montgomery's task group. Eighteen aircraft joined battle with American fighters and lost half their number. A smaller group of nine Japanese dive bombers of this force evaded U.S. aircraft and attacked Wasp and Bunker Hill but scored no hits; eight were shot down.

Chronic exposure to high level of nitrogen dioxide results in the allosteric inhibition of glutathione peroxidase and glutathione S-transferase, both of which are important enzymes found in the mucous membrane antioxidant defense system, that catalyse nucleophilic attack by reduced glutathione (GSH) on non-polar compounds that contain an electrophilic carbon and nitrogen. These inhibition mechanisms generates free radicals that causes peroxidation from the lipids in the mucous membrane leading to increased peroxidized erythrocyte lipids, a reaction that proceeds by a free radical chain reaction mechanism that result in oxidative stress. The oxidative stress on the mucous membrane causes the dissociation of the GSTp-JNK complex, oligomerization of GSTP and induction of the JNK pathway, resulting in apoptosis or inflammation of the bronchioles and pulmonary alveolus in mild cases. On migrating to the bloodstream, nitrogen dioxide poisoning results in an irreversible inhibition of the erythrocyte membrane acetylcholinesterase which may lead to muscular paralysis, convulsions, bronchoconstriction, the narrowing of the airways in the lungs (bronchi and bronchioles) and death by asphyxiation. It also causes a decrease in glucose-6-phosphate dehydrogenase which may results in glucose-6-phosphate dehydrogenase deficiency known as favism, a condition that predisposes to hemolysis (spontaneous destruction of red blood cells).

Sources: en.wikipedia.org

Frequently asked questions

Is BPC-157 approved for medical use?

It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.

What do human studies show?

Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.

Why is the mechanism unclear?

Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.

Is BPC-157 a naturally occurring compound?

The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.

Network